Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 165
Selected: 0
NCT IDTitle
NCT00741819Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects
NCT05564637A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
NCT02318186Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)
NCT03037580Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
NCT03794583Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT02573896Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
NCT01746485Three Times Daily Dosing of UT-15C
NCT03367312Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
NCT00643604Rapid Switch From Flolan to Remodulin in the Outpatient Clinic
NCT04677829Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)
NCT01494896Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
NCT04870333PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
NCT04865393Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function
NCT01557647Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
NCT02663895Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis
NCT02370095Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
NCT01588405Remodulin® to Oral Treprostinil Transition
NCT01268553Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
NCT04287478Bacteriophage Therapy in Patients With Urinary Tract Infections
NCT04850105A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT05101564Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer
NCT00963027Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil
NCT02261883Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
NCT03804944Converting HR+ Breast Cancer Into an Individualized Vaccine
NCT02279745Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension
NCT07116681Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension
NCT03950739Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso
NCT03012646Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
NCT01353040Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
NCT02074449Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)
NCT02847260Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)
NCT01104870A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
NCT02693171Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients
NCT00262106Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
NCT01477333Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
NCT01884038Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients
NCT06477640Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension
NCT04708782Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT01934582A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
NCT05421897Rapid Administration Pilot for Infusing Dinutuximab
NCT01165476Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities
NCT00159250Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
NCT00963001Effect of Food on the Pharmacokinetics of Oral Treprostinil
NCT06335407Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
NCT01393795Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients
NCT04005469Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
NCT00060996Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
NCT01750684AC105 in Patients With Acute Traumatic Spinal Cord Injury
NCT03497689EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
NCT03055234Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD)